IDIBELL on the media
Advances in precision oncology and hereditary cancer: researchers describe the clinical and molecular impact of mutations in key genes for DNA replication and repair
IDIBELL researchers have conducted an in-depth characterization of all known pathogenic variants in the POLE and POLD1 genes, which are essential for DNA repair and replication.
25 years of the Human Genome: AI and biological chemistry break in to help decode the secrets of the genome
A global initiative has been launched to help understand the genome with the help of AI and biological chemistry, and thus facilitate drug discovery.
Food addiction does not prevent the success of bariatric surgery, but it can increase the risk of weight regain
Food addiction is not a barrier to achieving significant weight loss, but it can increase the risk of regaining weight over the years.
Bioinformatics team drives significant improvements in hereditary cancer prevention and treatment
A bioinformatics team devises a reliable and open access guide to choosing the best bioinformatics tools for CNV detection.
Bellvitge participates in research that studies the lineages of pneumococcal serotype 8, the bacterium responsible for pneumococcal disease and pneumonia
Pneumococcal serotype 8 has become one of the main causes of invasive pneumococcal disease in Spain, both in adults and in the pediatric population.
A study led by Bellvitge links pressure in sport with eating disorders
An international study led by the HUB and IDIBELL has analyzed the impact of factors such as aesthetic pressure and disciplinary demands on people with eating disorders (EDs) who practice elite sports.
Catalonia promotes the first public bank of fecal microbiota in Spain to treat some serious intestinal infections
The Microbiota Bank of Catalonia, a pioneering initiative in the public sphere that positions the Catalan health system as a benchmark in the therapeutic use of faecal microbiota has been launched.
A study led by Bellvitge points out that fosfomycin can improve the treatment of bacteremia caused by S. aureus
Combining fosfomycin with other antibiotics can help eliminate the infection more quickly, however, is also associated with an increase in side effects.
